Diagnostic Medical Systems (FR:ALDMS) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Diagnostic Medical Systems (DMS Group) reported a 10% revenue increase in the first semester of 2024, with earnings of 22.9 million euros, signaling strong growth especially in their Radiology and Osteodensitometry activities. Despite a cyber attack, the company sustained growth with Radiology activity up 22% and Osteodensitometry up 14%. The firm’s gross margin also improved, rising three percentage points from the previous year.
For further insights into FR:ALDMS stock, check out TipRanks’ Stock Analysis page.